Advanced Medical Solutions Group plc (AIM:AMS)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 282.56
-0.44 (-0.16%)
Nov 11, 2026, 12:37 PM GMT
AIM:AMS Market Cap
AIM:AMS has a market cap or net worth of 612.59 million as of November 10, 2026. It is the 11,201st most valuable company in the world and the 260th biggest in the United Kingdom. Its market cap has increased by 33.67% in one year.
Market Cap
612.59M
Enterprise Value
685.60M
Revenue
233.63M
Global Rank
Country Rank
#260 United Kingdom
PE Ratio
170.75
ChartMarket Cap Chart
Since April 11, 2000, AIM:AMS's market cap has increased from 11.11M to 612.59M, an increase of 5,415.30%. That is a compound annual growth rate of 16.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 612.59M | 30.28% |
| Dec 31, 2025 | 470.21M | 11.01% |
| Dec 31, 2024 | 423.58M | -6.07% |
| Dec 29, 2023 | 450.96M | -19.69% |
| Dec 30, 2022 | 561.49M | -23.12% |
| Dec 31, 2021 | 730.32M | 39.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 218.17B |
| GSK plc | 76.35B |
| Haleon | 29.08B |
| Smith & Nephew | 9.55B |
| Spire Healthcare Group | 993.48M |
| CVS Group | 914.14M |
| Oxford Biomedica | 678.96M |
| Craneware | 342.04M |